US106573A - Improvement in medical compound - Google Patents
Improvement in medical compound Download PDFInfo
- Publication number
- US106573A US106573A US106573DA US106573A US 106573 A US106573 A US 106573A US 106573D A US106573D A US 106573DA US 106573 A US106573 A US 106573A
- Authority
- US
- United States
- Prior art keywords
- medical compound
- improvement
- compound
- medical
- tincture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title description 16
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 229940098465 Tincture Drugs 0.000 description 6
- 240000006523 Abies balsamea Species 0.000 description 4
- 235000007173 Abies balsamea Nutrition 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000003097 Artemisia absinthium Nutrition 0.000 description 2
- 240000001851 Artemisia dracunculus Species 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 239000004857 Balsam Substances 0.000 description 2
- 210000004204 Blood Vessels Anatomy 0.000 description 2
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 description 2
- 229960000846 Camphor Drugs 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 241000218645 Cedrus Species 0.000 description 2
- 235000015912 Impatiens biflora Nutrition 0.000 description 2
- 208000004296 Neuralgia Diseases 0.000 description 2
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010072736 Rheumatic disease Diseases 0.000 description 2
- 244000009660 Sassafras variifolium Species 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001396 anti-anti-diuretic Effects 0.000 description 2
- 239000001138 artemisia absinthium Substances 0.000 description 2
- 229940025250 camphora Drugs 0.000 description 2
- 239000010238 camphora Substances 0.000 description 2
- 239000001390 capsicum minimum Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000001882 diuretic Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000001926 lymphatic Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000552 rheumatic Effects 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 230000001256 tonic Effects 0.000 description 2
- 235000009051 wormwood Nutrition 0.000 description 2
- 235000017731 wormwood Nutrition 0.000 description 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
Definitions
- My invention has for its object to furnish, and consists in, the medical compound formed of the ingredicms hereinafter set forth.
- My improved compound is designed for internal and also external or local application to the human body, and, in this latter respect, to take the place of alcohol, which has been previously and is still used for producing local action when applied to the surface,
- This medicine is particularly applicable in nervous diseases, mostly rheumatic and neuralgia incharactcr, and by it I secure a quicker and more permanent action when'applied locally; and, as an agent for internal use, its action is not only to relieve pain temporarily, but decidedly to cure disease by meeting every requirement, by acting as alterative, tonic, stimulant, febril'uge, and diuretic, and as a powerful anodine.
Description
Tun-ital $21125 152mm (itililim Letters Patent No. 106,573, dated August 23, 187 0.
IMPROVEMENT IN MEDICAL COMPOUND.
The Schedule referred to in these Letters Patent and making part of the same.
To all whom it may concern.-
Be it known that I, Lnwis L. Grammar, M. IL, of New Providence, in the county of Clark, and State of Indiana, have invented a new and nsefnl'lmprovement in Medical Compound; and I do hereby declare that the following is a full, clear, and exact descrip- 'tion thereof, which will enable others skilled in the art to make and use the same.
My invention has for its object to furnish, and consists in, the medical compound formed of the ingredicms hereinafter set forth.
In comparing my improved medical compound, I use the following formula:
Balsam of fir; chloroform; nitric other; sulphuric other; sarsnparilla, fluid extract; tincture Oolumbo radix; tincture guaiacnm, ac f z ii; camphora; spirits tcrebinthine; oleuin cedar; oleum wintergrcen olcum Wormwood, a cf .1 i; oleum hemlock, f: i s s; tincture capsicum; olenm Sassafras, a a f :2 iii; flor. sambrccus cunadensis, z i alcohol, Oongpi. Mix.
My improved compound is designed for internal and also external or local application to the human body, and, in this latter respect, to take the place of alcohol, which has been previously and is still used for producing local action when applied to the surface,
and fol-affecting the system by absorption into the general circulation of the blood-vessel All the ingredients in my compound have not endesmotic properties, but, when combined with the others, .and particularly chloroform and ether, are readily taken up in the general circulation, by means of the lymphatics and absorbents.
This medicine is particularly applicable in nervous diseases, mostly rheumatic and neuralgia incharactcr, and by it I secure a quicker and more permanent action when'applied locally; and, as an agent for internal use, its action is not only to relieve pain temporarily, but decidedly to cure disease by meeting every requirement, by acting as alterative, tonic, stimulant, febril'uge, and diuretic, and as a powerful anodine.
Having thus described my invention,
I claim as new and desire to secure by Letters Patent- The medical compound, prepared of the ingredients and in the manner substantially as herein set forth and described.
LEWIS L. GEBHART, M. D. Witnesses:
HARVEY ORA/BB, CHARLES A. HOPEWELL.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US106573A true US106573A (en) | 1870-08-23 |
Family
ID=2176049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US106573D Expired - Lifetime US106573A (en) | Improvement in medical compound |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US106573A (en) |
-
0
- US US106573D patent/US106573A/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3773201D1 (en) | MEDICINE CONTAINING PROPYLENE GLYCOL AND / OR POLYAETHYLENE GLYCOL AND UREA AS THE MAIN INGREDIENTS. | |
| US106573A (en) | Improvement in medical compound | |
| Hornick et al. | Development or worsening of sarcoidosis associated with IL-17 blockade for psoriasis | |
| US87343A (en) | Improved medical compound | |
| Jori et al. | Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients | |
| US116530A (en) | Improvement in medical compounds for cure of cancer and other diseases | |
| US93209A (en) | Improved medical compound or | |
| US98875A (en) | Peter mays and price mays | |
| US121631A (en) | Improvement in medical extracts from hemlock bark | |
| US100057A (en) | Improved ointment for bruises, burns | |
| Ortega | Nanometric and vectorized gold as a potential strategy towards Treatment of Rheumatoid Arthritis | |
| US101722A (en) | Improvement in hair medicine | |
| US90308A (en) | Improved medical compound | |
| US116310A (en) | Improvement in medical compounds or bitters | |
| US104758A (en) | Improved medical compound | |
| US75732A (en) | Horace clark | |
| US139045A (en) | Improvement in medical compounds | |
| US123666A (en) | Improvement in medical compounds or ethereal oils for treating rheumatism | |
| US106127A (en) | Improved medical compound and liniment | |
| US93143A (en) | Improved uiiimbnt | |
| US128380A (en) | Improvement in preventives and remedies for hog-cholera | |
| DE854414C (en) | Process for the production of injectable solutions of more or less poorly soluble medicaments | |
| US114784A (en) | Improvement in compounds for cure of chills and fever | |
| US113569A (en) | Improvement in medical compounds | |
| Baek | The Story of people and architecture-Start, Critical point, Turning Point |